Science Explorer Interactive view Map
Nonprofit · Berlin · Germany

Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie

noggo.deROR OpenAlex
Research works
39
▲ 132% vs 2013–17
Citations
337
8.6 per fractional work
Top-10% rate
23.7%
record average 16.5%
Open access
48%
world 28%

Not ranked overall: Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.71× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 0.36× its world share, 0 worksImmunology and Micro…Neuroscience: 0.08× its world share, 0 worksNeuroscienceChemistry: 0.48× its world share, 0 worksChemistryComputer Science: 0.04× its world share, 0 worksComputer ScienceEngineering: 0.74× its world share, 2 worksEngineeringMaterials Science: 2.93× its world share, 2 worksMaterials SciencePhysics and Astronomy: 0.07× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.90× its world share, 0 worksHealth ProfessionsMedicine: 3.11× its world share, 9 worksMedicineNursing: 1.18× its world share, 0 worksNursingArts and Humanities: 0.19× its world share, 0 worksArts and HumanitiesEconomics, Econometrics and Finance: 1.48× its world share, 0 worksEconomics, Econometr…Psychology: 0.37× its world share, 0 worksPsychologySocial Sciences: 0.02× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.1×. Every wedge is a field page.

Which keywords describe research at Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie?

By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Clinical Trials, Ovarian Cancer, Cytoreductive Surgery, Biomarkers, Metastasis, Genomic Analysis and Tumor Models.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 39 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 39 words, with their numbers
  1. Chemotherapy9▲ 33×13 topics
  2. Clinical Trials8▲ 32×9 topics
  3. Ovarian Cancer8▲ 209×3 topics
  4. Cytoreductive Surgery7▲ 286×2 topics
  5. Biomarkers7▲ 29×4 topics
  6. Metastasis7▲ 52×5 topics
  7. Genomic Analysis7▲ 58×1 topic
  8. Tumor Models7▲ 281×1 topic
  9. Quality of Life3▲ 5.9×11 topics
  10. Breast Cancer2▲ 18×7 topics
  11. Survival Analysis2▲ 19×4 topics
  12. Cancer Therapy2▲ 7.5×4 topics
  13. Clinical Practice Guidelines2▲ 8.6×4 topics
  14. Public Health2▲ 3.5×6 topics
  15. BRCA Mutation2▲ 239×1 topic
  16. Cell Death2▲ 20×2 topics
  17. Depression2▲ 5.6×3 topics
  18. Health-related Quality of Life2▲ 19×3 topics
  19. Healthcare Utilization2▲ 53×2 topics
  20. Homologous Recombination2▲ 62×2 topics
  21. PARP Inhibitors2▲ 239×1 topic
  22. Physical Activity2▲ 11×3 topics
  23. Anxiety2▲ 11×2 topics
  24. Cancer2▲ 2.6×11 topics
  25. Chronic Diseases2▲ 14×3 topics
  26. Precision Medicine2▲ 12×3 topics
  27. Cancer Survivorship1▲ 62×2 topics
  28. Epidemiology1◆ 0.87×13 topics
  29. Patient-Reported Outcomes1▲ 94×1 topic
  30. Psychosocial Interventions1▲ 94×1 topic
  31. Germany1▲ 108×1 topic
  32. Health Surveys1▲ 108×1 topic
  33. Cervical Cancer1▲ 31×2 topics
  34. Clinical Guidelines1▲ 9.5×2 topics
  35. Guidelines1▲ 6.2×4 topics
  36. Immunotherapy1▲ 4.2×7 topics
  37. Molecular Classification1▲ 19×3 topics
  38. Tumor Microenvironment1▲ 8.1×3 topics
  39. Metastatic Breast Cancer1▲ 40×2 topics

Which research topics does Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie publish most on?

By volume in 2022–2025: Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, Cancer Immunotherapy and Biomarkers and Endometrial and Cervical Cancer Treatments.

Ovarian cancer diagnosis…3Ovarian cancer diagnosis and treatment: 3 fractional worksPARP inhibition in cancer therapy: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksEndometrial and Cervical Cancer Treatments: 1 fractional worksElectric and Hybrid Vehicle Technologies: 0 fractional worksEngineering and Materials Science Studies: 0 fractional worksCancer survivorship and care: 0 fractional worksOrthopedic Infections and Treatments: 0 fractional worksHydrogen embrittlement and corrosion behaviors in metals: 0 fractional worksIntraperitoneal and Appendiceal Malignancies: 0 fractional works
Reproductive MedicineOncologyObstetrics and GynecologyAutomotive Engineering3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Ovarian cancer diagnosis and treatment Reproductive Medicine 3 works
  2. 2 PARP inhibition in cancer therapy Oncology 1 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 1 works
  4. 4 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 1 works
  5. 5 Electric and Hybrid Vehicle Technologies Automotive Engineering 0 works
  6. 6 Engineering and Materials Science Studies Mechanical Engineering 0 works
  7. 7 Cancer survivorship and care Oncology 0 works
  8. 8 Orthopedic Infections and Treatments Surgery 0 works
  9. 9 Hydrogen embrittlement and corrosion behaviors in metals Metals and Alloys 0 works
  10. 10 Intraperitoneal and Appendiceal Malignancies Surgery 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.8%not open52.2%

World: 28% of research is openly available.

with international co-authors34.1%domestic only65.9%

World: 19% is written across borders.

How has Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie's research output changed?

Output in 2018–2022 was 132% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Berlin

All research institutions in Berlin

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.